Overview
PCVX market data
Price History
PCVX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$5.63 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.22 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $29.08 – $65.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $8K · P/B 2.25.
Company news
8-K filing — Vaxcyte, Inc. (PCVX)SEC EDGAR · Jul 15, 2026, 8:05 PM
Vaxcyte Announces First Patient Enrollment In Phase 1 Study Evaluating Group A Streptococcus Vaccine VAX-A1Benzinga · Jun 2, 2026, 8:09 PM
Top 3 Health Care Stocks You'll Regret Missing In MayBenzinga · May 26, 2026, 10:08 AM
Pfizer Expands Pneumococcal Vaccine Push With New ProgramsBenzinga · May 20, 2026, 2:15 PM